Zhejiang Medicine announces share repurchase plan up to CNY 200m
Zhejiang Medicine Co., Ltd. announced a share repurchase plan, aiming to acquire shares worth between CNY 100 million and CNY 200 million. The shares will be repurchased through centralized bidding transactions and will be used for employee stock ownership plans or equity incentives. The repurchase price will not exceed CNY 20.83 per share. The company will fund the repurchase from its own funds or self-raised funds. The repurchase period will not exceed 12 months from the date of board approval. Guotou Hi-Tech, a shareholder holding more than 5% of the company, intends to reduce its holdings. The repurchase will not affect the company’s listing status and will enhance investor confidence.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Zhejiang Medicine publishes news
Free account required • Unsubscribe anytime